The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, double-blind, phase II clinical trial of GI-6301 (yeast-brachyury vaccine) versus placebo in combination with standard of care definitive radiotherapy in locally advanced, unresectable, chordoma.
 
Peter Joseph DeMaria
No Relationships to Disclose
 
Marijo Bilusic
Research Funding - Bavarian Nordic (Inst); ImmunityBio (Inst)
 
Deric Park
No Relationships to Disclose
 
Christopher Ryan Heery
Employment - Bavarian Nordic; Precision Biosciences
Leadership - Bavarian Nordic; Precision Biosciences
Stock and Other Ownership Interests - Bavarian Nordic; Istari; Precision Biosciences
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
Research Funding - Bayer
 
Julius Strauss
Research Funding - EMD Serono (Inst); Etubics (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on NIH pending patent (Inst)
 
Renee Nicole Donahue
No Relationships to Disclose
 
Jenn Marte
No Relationships to Disclose
 
Mark R. Gilbert
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
Jeffrey Schlom
Research Funding - EMD Serono/Merck (Inst); EMD Serono/Merck (Inst)
Patents, Royalties, Other Intellectual Property - If applicable; If applicable (Inst)
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Merck (Inst); NantBioScience (Inst); Pfizer (Inst)